James Voglino, MD
Orthopaedic Surgery · Miami, FLNPI 1194747642
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (41.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Arthrex at 51.9% of the total. Reporting peaked in 2023 at $1,327 and has fallen 86.0% since, to $185 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in FL, where the typical reported total is $5,564.
Across 54 payments — averaging $57.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Southern Edge Orthopaedics, Inc.$1K
- Electronic Waveform Lab, Inc.$141
- Medical Device Business Services, Inc.$112
- Anika Therapeutics, Inc.$71
- Pacira Pharmaceuticals Incorporated$41
- plus $123 from 5 others
What the payments were for
- Travel & lodging$1,27641%
- Food & beverage$96531%
- Education$87228%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 25 | $1,616 |
| Southern Edge Orthopaedics, Inc. | 2 | $1,009 |
| Electronic Waveform Lab, Inc. | 18 | $141 |
| Medical Device Business Services, Inc. | 1 | $112 |
| Anika Therapeutics, Inc. | 1 | $71 |
| Pacira Pharmaceuticals Incorporated | 2 | $41 |
| ERMI LLC | 1 | $33 |
| Johnson & Johnson | 1 | $32 |
| Fidia Pharma USA Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Smith+Nephew | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TFN ADVANCED$112
How this compares
$3,114 in reported general payments places this provider in the 35th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 20 | $826 |
| Meloxicam | 69 | $133 |
| Naproxen | 11 | $98 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Miami
- Charles LawrieMiami$1.7M
- Rolando GarciaMiami$1M
- Charles JordanMiami$817K
- Francis HornicekMiami$790K
- Aldo RiesgoMiami$709K
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.